1. Prestayko AW. Cisplatin: A preclinical overview. In: Prestayko AW, Crooke ST, Carter SK, eds. Cisplatin: Current Status and New Developments. New York: Academic Press, 1980:1–7.
2. Skipper HE. A review and more quantitative analysis of the results of many internally controlled combination chemotherapy trials carried out over the past 15 years (L1210 and leukemia and P388 leukemia). Southern Res Inst 1979; monograph #2.
3. Schabel FM, Jr., Skipper HE, Trader MW. Concepts for controlling drug-resistant tumor cells. In: Mouridsen HT, Palshof T, eds. Breast Cancer: Experimental and Clinical Aspects. Oxford: Pergamon Press, 1980:199–212.
4. Goldie H, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979; 63:1727–1733.
5. DeMrs R. Resistance of cultured human fibroblasts and other cells to purine analogs in relation to mutagenesis detection. Mutation Res 1974; 14:335.